SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests
3 references·13 citing·42 second hop
Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests (1995)Post-transfusion hepatitis: impact of non…The Risk of Transfusion-Transmitted Infection (1992)The Risk of Transfusion-Trans…Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for Non-A, Non-B Hepatitis Agents in Donated Blood (1986)Antibody to Hepatitis B Core …Calculation of Polychotomous Logistic Regression Parameters Using Individualized Regressions (1984)Calculation of Polychotomous …A Framework for Applying the Precautionary Principle to Transfusion Safety (2011)A Framework for Applying the …Variant Creutzfeldt–Jakob disease and the Canadian blood system after the tainted blood tragedy (2006)Variant Creutzfeldt–Jakob dis…Emerging Infectious Threats to the Blood Supply (2004)Emerging Infectious Threats t…Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT (2002)Assessing the accuracy of thr…Genomic screening for blood-borne viruses in transfusion settings (2000)Genomic screening for blood-b…Study of serum alanine-aminotransferase levels in blood donors in Spain. (1998)Study of serum alanine-aminot…Prevalence of HBsAg and Anti-HCV in Saudi Blood Donors (1998)Prevalence of HBsAg and Anti-…Hepatitis C lookback (1998)Hepatitis C lookbackValue and cost‐effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window‐phase human immunodeficiency virus type 1 infections (1997)Value and cost‐effectiveness …Risk Factors and Anti‐HBc Reactivity among First Time Blood Donors (1997)Risk Factors and Anti‐HBc Rea…Dépistage et détection précoce en transfusion sanguine : quand sont-ils indiqués ? (1997)Dépistage et détection précoc…Relationship between antibody to hepatitis B core antigen and retroviral infections in blood from volunteer donors (1996)Relationship between antibody…A history of the evolution of hepatitis C testing of blood donors: implications for the Canadian blood supply system (1995)A history of the evolution of…The Risk of Transfusion-Transmitted Viral Infections (1996)The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)Residual risk of transfusion‐transmitted viral infections in Shenzhen, China, 2001 through 2004 (2007)The Risk of HIV, HBV, HCV and HTLV Infection Among Musculoskeletal Tissue Donors in Australia (2007)A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus (2008)Donor transaminase and recipient hepatitis. Impact on blood transfusion services (1981)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Science and the Precautionary Principle (2000)The Politics of Blood (2012)Risk‐based decision making in transfusion medicine (2018)Malaria blood safety policy in five non-endemic countries: a retrospective comparison through the lens of the ABO risk-based decision-making framework. (2019)Mini‐pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results (1998)Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Prevention of transfusion‐transmitted hepatitis E by donor‐initiated self exclusion (2005)Surveillance of risk profiles among new and repeat blood donors with transfusion‐transmissible infections from 1995 through 2003 in the Netherlands (2006)Prevalence of HIV among blood donors in a tertiary care centre of north India (2011)Hepatitis B Virus Antibody in Blood Donors and the Occurrence of Non-A, Non-B Hepatitis in Transfusion Recipients (1984)Prevalence of Human Immunodeficiency Virus Type 1 p24 Antigen in U.S. Blood Donors — An Assessment of the Efficacy of Testing in Donor Screening (1990)Riesgo de enfermedades infecciosas transmitidas por transfusión en el Valle del Cauca, Colombia. (1999)[Risk of transfusional-transmitted infections]. (2002)Evaluation of surrogate markers for human immunodeficiency virus infection among blood donors at the blood bank of "Hospital Universitário Regional Norte do Paraná", Londrina, PR, Brazil (2003)Tropical Infectious Diseases: Principles, Pathogens, and Practice (2000)Blood Safety in the New Millennium (2002)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Current Safety of the Blood Supply in the United States (2004)Emerging viral threats to the Australian blood supply (2008)Viral Metagenomics for Identification of Emerging Viruses in Transfusion Medicine (2022)Clinical Decision Analysis (1980)The Markov Process in Medical Prognosis (1983)Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis (1999)Equity and the economic evaluation of healthcare (2001)Serum alanine aminotransferase levels among volunteer blood donors: effect of sex, alcohol intake and obesity. (1992)Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study (1995)Public health service interagency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C (1991)Safety of the Blood Supply (1995)Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century (2012)Collection and transfusion of blood and blood components in the United States, 1992 (1995)Collection and transfusion of blood and blood components in the United States, 1994 (1998)Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood (2000)Incidence of Major Depressive Disorder and Dysthymia in Young Adolescents (1997)Control of the Commission's Executive Functions (2000)Testing for IIA in the Multinomial Logit Model (2007)
this work references cited by second hop

References

  • 1992The Risk of Transfusion-Transmitted Infection415 cited
  • 1986Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for Non-A, Non-B Hepatitis Agents in Donated Blood328 cited
  • 1984Calculation of Polychotomous Logistic Regression Parameters Using Individualized Regressions251 cited

Cited by

  • 2002Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT78 cited
  • 2004Emerging Infectious Threats to the Blood Supply60 cited
  • 2000Genomic screening for blood-borne viruses in transfusion settings58 cited
  • 2011A Framework for Applying the Precautionary Principle to Transfusion Safety33 cited
  • 1997Value and cost‐effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window‐phase human immunodeficiency virus type 1 infections32 cited
  • 1996Relationship between antibody to hepatitis B core antigen and retroviral infections in blood from volunteer donors21 cited
  • 1998Study of serum alanine-aminotransferase levels in blood donors in Spain.20 cited
  • 1998Hepatitis C lookback20 cited
  • 2006Variant Creutzfeldt–Jakob disease and the Canadian blood system after the tainted blood tragedy17 cited
  • 1997Risk Factors and Anti‐HBc Reactivity among First Time Blood Donors14 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 1998Prevalence of HBsAg and Anti-HCV in Saudi Blood Donors13 cited
  • 1997Dépistage et détection précoce en transfusion sanguine : quand sont-ils indiqués ?11 cited
  • 1995A history of the evolution of hepatitis C testing of blood donors: implications for the Canadian blood supply system6 cited